Corynebacterium Diphtheriae

Sample for Corynebacterium Diphtheriae

• The swab is made from the throat or from the suspected lesion.

Indication for Corynebacterium Diphtheriae

• For the diagnosis of C. Diphtheriae (Diphtheria)

Microbiology of Corynebacterium Diphtheriae

1. C. diphtheriae is a nonmotile, non-capsulated, club-shaped, Gram-positive bacillus.
   1. These are non-sporing.
   2. Highly pleomorphic-like Chinese letter appearance.
2. Habitat is the throat and nose of human beings.
3. These are pleomorphic gram-positive rods or clubs which divide in unique patterns like V, L, or W shapes, the so-called Chinese character shapes.
   1. These rods measure 3 x 0.3 µm.
4. Culture:
   1. These are aerobes and facultative anaerobes.
   2. The optimum temperature for the growth is 37 °C.
   3. Media containing blood or serum is needed.
   4. Selective media is needed for isolation.
   5. Most strains require nicotinic and pantothenic acids for growth; some also require thiamine, biotin, or pimelic acid.
5. The selective medium is used:
   1. Loeffler’s medium (coagulated blood serum.
      1. Take the growth after 12 hours and stain the growth with methylene blue, showing rod-shaped pleomorphic bacteria.
   2. Potassium tellurite medium.
      1. The colonies are black to gray within 24 hours of the culture.
6. The medium should be supplemented with amino acids for optimal production of diphtheria toxin.
7. Biochemical reactions:
   1. There is acid production from carbohydrates.
   2. Gravis strain can ferment starch and sugar.
   3. Intermedius and mitis can not ferment.

8. Toxigenic strains are lysogenic.
   1. These toxigenic strains cause the death of the experimental animal in 2 to 3 days,
   2. While antitoxin-protected animals can survive.
9. Corynebacterium diphtheriae subtypes are based on colony morphology:
   1. Mitis.
   2. intermedius.
   3. Gravis.
10. For epidemiological studies, the C. diphtheriae typing is done by:
    1. Serotyping.
    2. Phage typing.
    3. Bacteriocin typing.

Pathogenesis of Corynebacterium Diphtheriae:

1. The asymptomatic nasopharyngeal carriage is common in regions where diphtheria is endemic.
2. In susceptible individuals, toxigenic strains cause disease by multiplying and secreting diphtheria toxin in either the nasopharyngeal area or skin lesions.
3. There is often the formation of a pseudomembrane composed of fibrin, bacteria, and inflammatory cells.
4. The necrosis of the affected epithelium forms a pseudomembrane of fibrin, necrotic cells, and neutrophils.

5. After absorption into the blood, the toxin acts systemically on the myocardium, nervous tissue, and adrenal gland.
6. Only the motor nerves are affected.
7. Diphtheria toxin can be proteolytically cleaved into two fragments:
   1. Fragment A catalyzes the NAD+-dependent ADP-ribosylation.
   2. Fragment B binds to the cell surface receptor and facilitates the delivery of fragment A to the cytosol.
   3. The toxin can be inactivated by treating it with formaldehyde, and there is the formation of toxoids.
      1. Toxoid is used for immunization.

Clinical presentation of Corynebacterium Diphtheriae (Signs and symptoms):

1. C. diphtheriae infects the nasopharynx or skin.
2. Toxigenic strains secrete a potent exotoxin which may cause diphtheria.
3. The symptoms of diphtheria include:
   1. Pharyngitis.
   2. Fever.
   3. Swelling of the neck or area surrounding the skin lesion.
4. Diphtheritic lesions:
5. These are covered by a pseudomembrane.
6. The toxic outcome is that toxin is distributed to distant organs by the circulatory system and may cause:
   1. Paralysis.
   2. Congestive heart failure.
   3. These are the clinical signs of nasopharyngeal diphtheria infection:
      1. A sore throat.
      2. Dysphagia.
      3. Bloody nasal discharge.
      4. Pseudomembrane formation.

Diagnosis of Corynebacterium Diphtheriae:

1. Clinical diagnosis depends upon culture-proven toxigenic C. diphtheriae infection of :
   1. The skin.
   2. Nose or throat.
2. Toxigenicity is identified by a variety of in vitro (e.g., gel immunodiffusion, tissue culture) or in vivo (e.g., rabbit skin test, guinea pig challenge).
3. This bacteria is Urease negative.
4. Schick test:
   1. This is a skin test to find immunity for circulating diphtheria antitoxin.
   2. This test indicates either previous immunization or infection.
   3. Inject intradermally on an anterior aspect of the forearm toxin.
   4. Also, inject a heat-inactivated toxin into another arm.
      1. Result: The positive test is erythema at the site of injection.
      2. Negative erythema on the heat-inactivated arm.
         1. The arm should be examined after 1 to 2 days.
         2. Again examine after 5 to 7 days.
5. Special stain:
   1. Albert’s stain.
   2. Another stain used is Ponder’s stain.

Staining procedure:

1. Cover the fixed and dried slide with Loeffler’s methylene blue. Leave for 5 minutes.
2. Wash with water.
3. Decolorize with sulphuric acid with a dilution of 1/1000 immediately.
4. Acid should not stay for more than a few seconds.
5. Again wash with water.
6. Treat with Gram’s iodine.
7. Again wash with water.
8. Counterstain with 1% eosin for 30 seconds.
9. Wash with water and dry it.

Result of staining:

• Metachromatic granules are seen on the smear.
• The body of the bacteria is pinkish, and the granules are blue-black.
  • Gram stain also shows gram-positive bacteria.

Treatment Corynebacterium Diphtheriae:

1. Give supportive treatment.
2. Give antitoxin, which will neutralize the diphtheria toxins. This will be effective in the early stages when the toxins have not reached the target organs.
3. Antibiotics like penicillin or erythromycin will kill the bacteria. It will make patients noncontagious.
4. The vaccine should be given because the patient doesn’t develop immunity to future infection.
   1. DPT (Diphtheria, pertussis, and tetanus) vaccine is given.

Questions and answers: